Background/Aim: Dietary protein restriction is known to be beneficial in the preservation of the renal function in patients with chronic renal failure. Recently, the effect of varying quantity and quality of dietary protein intakes was also studied. This study investigates the effects of different dietary animal proteins on renal function in spontaneously hypercholesterolemic Imai rats that exhibit renal lesions similar to human focal and segmental glomerulosclerosis. The sources of proteins were from casein, pork, and fish. Primary concern was the effect of fish meat protein, because the effects of fish oil are well reported. To examine whether remnants of fish oil affect the experimental results, semi-defatted fish meat and fully defatted fish meat were prepared for these experiments. Methods: Forty-two Imai rats were placed on diets containing casein, defatted pork meat, semi-defatted fish meat, or defatted fish meat as a protein sources from 10 to 22 weeks of age. Twenty-four hour urine collections were obtained along with measurements of systolic blood pressure and drawing blood from the tail artery every 4 weeks. Finally, the kidneys were removed and prepared for histological study. Results: The semi-defatted fish meat diet retarded the rise of plasma cholesterol, virtually completely prevented the development of hypertriglyceridemia, and slowed the progression of proteinuria, renal function failure, and glomerular injury as compared with the control casein diet. However, the fully defatted fish meat diet led to renal failure at the same rate as the casein diet. The defatted pork diet group exhibited a higher creatinine clearance at the end of the experiments as compared with the casein and the fully defatted fish meat diet groups. Conclusions: These data suggest that an important determinant of the protective effects of the semi-defatted fish meat diet was related to the prevention of hypercholesterolemia and hypertriglyceridemia by the remaining fish oil. Fish meat protein itself did not indicate superior beneficial effects in the regression of the renal function in Imai rats as compared with casein protein, and defatted pork showed better results than casein and fully defatted fish meat.

Journal Section:
Original Paper
Keywords:
Angiotensin-converting enzyme, Dietary protein intake, Renal failure progression, Fish oil, Spontaneously hypercholesterolemic Imai rat
1.
Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996;124:627–632.
[PubMed]
2.
Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ: Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993;16:483–492.
[PubMed]
https://doi.org/10.2337%2Fdiacare.16.2.483
3.
Percheron C, Colette C, Astre C, Monnier L: Effects of moderate changes in protein intake on urinary albumin excretion in type I diabetic patients. Nutrition 1995;11:345–349.
[PubMed]
4.
Fouque D, Wang P, Laville M, Boissel JP: Low-protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 2000;15:1986–1992.
[PubMed]
https://doi.org/10.1093%2Fndt%2F15.12.1986
5.
Ideura T, Shimazui M, Higuchi K, Morita H, Yoshimura A: Effect of nonsupplemented low-protein diet on very late stage CRF. Am J Kidney Dis 2003;41(3 Suppl 1): S31–S34.
https://doi.org/10.1053%2Fajkd.2003.50080
6.
Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P, Borsato M, Sacerdoti D, Viberti G: Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990;38:136–144.
[PubMed]
https://doi.org/10.1038%2Fki.1990.178
7.
Williams AJ, Baker F, Walls J: Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats. Nephron 1987;46:83–90.
[PubMed]
https://doi.org/10.1159%2F000184312
8.
Maddox DA, Alavi FK, Silbernick EM, Zawada ET: Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int 2002;61:96–104.
[PubMed]
https://doi.org/10.1046%2Fj.1523-1755.2002.00091.x
9.
Soroka N, Silverberg DS, Greemland M, Birk Y, Blum M, Peer G, Iaina A: Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron 1998;79:173–180.
[PubMed]
https://doi.org/10.1159%2F000045021
10.
Cupisti A, Morelli E, Meola M, Barsotti M, Barsotti G: Vegetarian diet alternated with conventional low-protein diet for patients with chronic renal failure. J Ren Nutr 2002;12:32–37.
[PubMed]
https://doi.org/10.1053%2Fjren.2002.29595
11.
Kitazato H, Fujita H, Shimotomai T, Kagaya E, Narita T, Kakei M, Ito S: Effects of chronic intake of vegetable protein added to animal or fish protein on renal hemodynamics. Nephron 2002;90:31–36.
[PubMed]
https://doi.org/10.1159%2F000046311
12.
Nakamura H, Ito S, Ebe N, Shibata A: Renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care 1993;16:1071–1075.
[PubMed]
https://doi.org/10.2337%2Fdiacare.16.8.1071
13.
Mune M, Meydani M, Gong J, Fotouhi N, Ohtani H, Smith D, Blumberg JB: Effect of dietary fish oil, vitamin E, and probucol on renal injury in the rat. J Nutr Biochem 1999;10:539–546.
[PubMed]
https://doi.org/10.1016%2FS0955-2863%2899%2900042-X
14.
Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC: The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol 1999;10:1772–1777.
[PubMed]
15.
Svensson M, Christensen JH, Solling J, Schmidt EB: The effect of n–3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis 2004;44:77–83.
[PubMed]
https://doi.org/10.1053%2Fj.ajkd.2004.03.024
16.
Mollsten AV, Dahlquist GG, Stattin EL, Rudberg S: Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care 2001;24:805–810.
[PubMed]
https://doi.org/10.2337%2Fdiacare.24.5.805
17.
Imai Y, Matsumura H, Miyajima H, Oka K: Serum and tissue lipids and glomerulonephritis in the spontaneously hypercholesterolemic (SHC) rat, with a note on the effects of gonadectomy. Atherosclerosis 1977;27:165–178.
[PubMed]
https://doi.org/10.1016%2F0021-9150%2877%2990054-5
18.
Kondo S, Yoshizawa N, Wakabayashi K: Natural history of renal lesions in spontaneously hypercholesterolemic (SHC) male rats. Nippon Jinzo Gakkai Shi 1995;37:91–99.
[PubMed]
19.
Reeves PG, Rossow KL, Lindlauf J: Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr 1993;123:1923–1931.
[PubMed]
20.
Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137–143.
[PubMed]
https://doi.org/10.1038%2Fki.1984.147
21.
Vyberg M, Nielsen S: Dextran polymer conjugate two-step visualization system for immunohistochemistry. Appl Immunohistochem 1998;6:3–10.
https://doi.org/10.1097%2F00022744-199803000-00002
22.
Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985;312:1210–1216.
[PubMed]
https://doi.org/10.1056%2FNEJM198505093121902
23.
Sinha AK, Scharschmidt LA, Neuwirth R, Holthofer H, Gibbons N, Arbeeny CM, Schlöndorff D: Effects of fish oil on glomerular function in rats with diabetes mellitus. J Lipid Res 1990;31:1219–1228.
[PubMed]
24.
Schmidt EB, Kristensen SD, De Caterina R, Illingworth DR: The effects of n–3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 1993;103:107–121.
[PubMed]
https://doi.org/10.1016%2F0021-9150%2893%2990254-R
25.
Seki E, Osajima K, Matsufuji H, Matsui T, Osajima Y: Angiotensin II converting enzyme inhibitory activity of the short-chain peptides derived from various food proteins. Nippon Shokuhin Kagaku Kogaku Kaishi 1996;43:839–840.
26.
Astawan M, Wahyuni M, Yasuhara T, Yamada K, Tadokoro T, Maekawa A: Effects of angiotensin-I-converting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats. Biosci Biotechnol Biochem 1995;59:425–429.
[PubMed]
https://doi.org/10.1271%2Fbbb.59.425
27.
Fujita H, Yoshikawa M: LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 1999;44:123–127.
[PubMed]
https://doi.org/10.1016%2FS0162-3109%2899%2900118-6
28.
Kawasaki T, Seki E, Osajima K, Yoshida M, Asada K, Matsui T, Osajima Y: Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 2000;14:519–523.
[PubMed]
https://doi.org/10.1038%2Fsj.jhh.1001065
© 2007 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2007
You do not currently have access to this content.